If the goal of these cuts was to make the government leaner, the result has been to make it weaker. And in the realm of public health, weakness can be deadly.

Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration ...

A pivotal trial of an electronic artificial urinary sphincter could herald the future of treating incontinence.

The Artificial Urinary Sphincter Clinical Outcomes Trial (AUSCO) represented the first attempt at rigorous application of the ...

A brain-computer interface that allowed a man, 45, with ALS to communicate using recordings of his own voice has won a $7,500 ...

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield ("Anthem") has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for ...

The INTEGRA-D ™ trial is a multicenter, prospective, single-arm study evaluating the safety and efficacy of CCM-D ® HF System ...

While physician-scientists are supported in splitting their time between research and clinical work, nurse-scientists are not ...

The world's first integrated CT ring linear accelerator was put into clinical use at Shanghai Renji Hospital on Saturday, ...

Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic ...

Several ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety, and efficiency in healthcare.

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...